Pergolide in Parkinson's disease

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Parkinson's disease is a progressive neurodegenerative disorder.
• Current treatments aim to manage motor symptoms and improve quality of life.

Purpose of the Study:

• To evaluate the long-term efficacy and safety of pergolide mesylate in Parkinson's disease patients.
• To assess changes in functional scores and "on-off" fluctuations.

Main Methods:

• A one-year study involving 22 Parkinson's disease patients.
• Regular assessment of functional scores and "on-off" fluctuation severity.

Main Results:

• Maximal improvement in functional scores was observed at six months.
• Average functional scores remained significantly better at 12 months compared to baseline.
• Reduced severity of "on-off" fluctuations, with two patients achieving full resolution.

Conclusions:

• Pergolide mesylate demonstrates sustained efficacy in improving motor function for Parkinson's disease patients over one year.
• The medication is well-tolerated and considered a safe, effective ongoing treatment option.